Both in Diagnostics
VolitionRx Limited vs Insight Molecular Diagnostics
Over the past year VNRX returned −97.9% and IMDX returned −48.9%; their daily moves had a correlation of -0.03.
VNRX −97.9% IMDX −48.9%Growth of $1, one year, split-adjusted
| Metric | VNRX | IMDX |
|---|---|---|
| Price | $0.1818 | $3.18 |
| Market cap | $5.5M | $104.1M |
| Today | −1.73% | +0.63% |
| 1 month | −29.0% | −5.9% |
| 6 months | −93.1% | −17.0% |
| Year to date | −96.4% | −57.6% |
| 1 year | −97.9% | −51.1% |
| Revenue growth (YoY) | −2.0% | −53.9% |
| Gross margin | 100.0% | 65.7% |
| Net margin | −1953.1% | −4711.3% |
| P/E (TTM) | — | — |
| Price / sales | 2.2× | 62.3× |
| Net cash | -$8.3M | $17.8M |
| Dividend yield | — | — |
| Volatility (60d) | 113.6% | 94.6% |
| Short % of float | 5.1% | 3.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).